Quick Answer
CV Sciences, Inc. reported Operating Income of -$470.0 thousand for fiscal year 2025.
CV Sciences, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$470.0K | +78.5% |
| 2024 | -$2.19M | -165.2% |
| 2023 | $3.36M | +149.1% |
| 2022 | -$6.85M | +62.9% |
| 2021 | -$18.45M | +18.4% |
| 2020 | -$22.59M | -31.0% |
| 2019 | -$17.24M | -268.2% |
| 2018 | $10.25M | +310.8% |
| 2017 | -$4.86M | +62.8% |
| 2016 | -$13.07M | -16.6% |
| 2015 | -$11.21M | -31.1% |
| 2014 | -$8.55M | -428.8% |
| 2013 | -$1.62M | -3659.7% |
| 2012 | -$43.0K | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$275.0K | +19.4% | -109.9% |
| June 30, 2025 | -$131.0K | +77.5% | -1290.9% |
| March 31, 2025 | $11.0K | +101.8% | +103.2% |
| September 30, 2024 | -$341.0K | +22.0% | +41.5% |
| June 30, 2024 | -$583.0K | +45.8% | +6.0% |
| March 31, 2024 | -$620.0K | -110.8% | -41.9% |
| September 30, 2023 | -$437.0K | +51.0% | +59.4% |
| June 30, 2023 | -$1.08M | +53.5% | -118.7% |
- CV Sciences, Inc. showed an increase of +78.5% in Operating Income compared to the prior fiscal year.
- Over the 2012–2025 period, CV Sciences, Inc.’s operating income has declined by 992.6% (from -$43.0 thousand to -$470.0 thousand).
- The most recent figure is from CV Sciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: